1.87% -0.1706

Evolus Inc (EOLS)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Evolus Inc Stock (EOLS) Company Profile

Healthcare (1087)

(949) 284-4555

520 NEWPORT CENTER DRIVE, NEWPORT BEACH

@evolusaesthetic

Nächster Verdiensttermin

Neueste SEC-Einreichungen

EOLS's Discussions on Twitter

Compare EOLS vs TAK, TEVA, HLN, ZTS, UTHR

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
EOLS Evolus Inc	8.705	586.53M	301.79M	-43.42M	-44.87M	-0.6705
TAK Takeda Pharmaceutical Co Adr	18.29	58.50B	29.91B	1.30B	3.49B	0.4056
TEVA Teva Pharmaceutical Industries Ltd Adr	36.69	42.84B	17.53B	1.58B	444.18M	1.3457
HLN Haleon Plc Adr	9.175	40.68B	14.54B	2.22B	2.58B	0.4871
ZTS Zoetis Inc	73.51	30.40B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	499.37	21.36B	3.17B	1.29B	1.01B	27.09

Evolus Inc Stock (EOLS) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-08-06	Herabstufung	Needham	Buy → Hold
2025-04-17	Eingeleitet	BTIG Research	Buy
2024-01-29	Hochstufung	Barclays	Equal Weight → Overweight
2022-06-23	Eingeleitet	Needham	Buy
2022-05-12	Hochstufung	Barclays	Underweight → Equal Weight
2022-01-20	Hochstufung	Truist	Hold → Buy
2021-05-06	Hochstufung	Mizuho	Neutral → Buy
2021-04-08	Bestätigt	H.C. Wainwright	Buy
2021-02-24	Herabstufung	Truist	Buy → Hold
2020-07-07	Herabstufung	Mizuho	Buy → Neutral
2020-02-06	Fortgesetzt	Mizuho	Buy
2019-11-26	Eingeleitet	SVB Leerink	Outperform
2019-09-05	Fortgesetzt	Mizuho	Buy
2019-06-28	Eingeleitet	Wells Fargo	Market Perform
2019-06-11	Eingeleitet	Barclays	Underweight
2019-03-20	Eingeleitet	SunTrust	Buy
2019-02-14	Eingeleitet	H.C. Wainwright	Buy
2019-01-29	Eingeleitet	Stifel	Buy

Alle ansehen

Evolus Inc Aktie (EOLS) Neueste Nachrichten

Finanzdaten der Evolus Inc-Aktie (EOLS)

Evolus Inc (EOLS)

Evolus Inc Stock (EOLS) Company Profile

Compare EOLS vs TAK, TEVA, HLN, ZTS, UTHR

Evolus Inc Stock (EOLS) Upgrades & Downgrades

Evolus Inc Aktie (EOLS) Neueste Nachrichten

Evolus (EOLS) Notches A Profit Milestone While Betting Big On The Future - Yahoo Finance

Evolus Insider MOATAZEDI DAVID Sells 105,108 Shares at $9.04 Each (NASDAQ: EOLS) - Kalkine Media

Evolus president & CEO David Moatazedi sells $950,018 in shares By Investing.com - Investing.com South Africa

Evolus president & CEO David Moatazedi sells $950,018 in shares - Investing.com India

Evolus Officer Sold Shares Worth Over $950K - TradingView

Insider at Evolus (NASDAQ: EOLS) moves to sell nearly $1M in stock - Stock Titan

Evolus (EOLS) Advances 2.36% to $9.09, Holding Ground Above SupportRange Breakout - dars.gov.et

Evolus (EOLS) adds Soleus group as new 5.3% shareholder - Stock Titan

(EOLS) Movement as an Input in Quant Signal Sets - news.stocktradersdaily.com

Evolus, Inc. (EOLS) Reports Break-Even Earnings for Q2 - Eastern Progress

Wall Street Analysts Think Evolus (EOLS) Could Surge 77.68%: Read This Before Placing a Bet - Eastern Progress

Evolus (EOLS) Earnings Update: The EPS Result Is Above Expectation in the Current Update; Market Response: Shares Move Higher 2.22% on the DayEarnings Decline Risk - vinanet.vn

Evolus (EOLS) Results Check: EPS Prints Above Forecast in the Latest Reading; Trading Move - vinanet.vn

EOLS | Evolus, Inc. Common Stock FinancialsRevenue Breakdown - Quiver Quantitative

Evolus (EOLS) Quarter in Focus: EPS Comes in Above Forecast on the Day; Share Move - vinanet.vn

Evolus (EOLS) Quarter in Focus: EPS Comes in Above Forecast on the Day; Share Move: The Share Price Adds 5.28% in the Current UpdatePretax Income Report - dars.gov.et

Evolus (EOLS) Closing Note: Records a 5.28% Increase to $8.18 in the Latest Session; the Price Remains Bounded by the Supplied Support and Resistance in the Available RecordBearish Sentiment - vinanet.vn

EOLS Q2 2026 Earnings: EPS Turns Positive, Delivering 156.82% Surprise vs. EstimatesCost Structure Review - vinanet.vn

August 2026's Leading Growth Companies With Insider Confidence - Sahm

Midday Stock Roundup: Mobix Labs Shares Fall 21% at Midday - ocbj.com

Renaissance Technologies LLC Lowers Stake in Evolus, Inc. $EOLS - marketbeat.com

Evolus, Inc. (EOLS) Stock Price, News, Quote & History - Yahoo! Finance Canada

Assenagon Asset Management S.A. Grows Stock Holdings in Evolus, Inc. $EOLS - marketbeat.com

EOLS Q2 2026 Earnings: EPS Surprises to the Upside as Shares SlipReturn On Equity - vinanet.vn

Evolus (NASDAQ:EOLS) Reaches New 1-Year HighHere's What Happened - MarketBeat

Wall Street Analysts Believe Evolus (EOLS) Could Rally 106.08%: Here's is How to Trade - Yahoo Finance

Evolus: The Injectable Platform Is Becoming The Real Moat (NASDAQ:EOLS) - Seeking Alpha

EOLS Q2 2026 Earnings: EPS of $0.02 Beats Estimates by 156.8% as Profitability Inflection EmergesSpecial Dividend Alert - vinanet.vn

Trading Systems Reacting to (EOLS) Volatility - Stock Traders Daily

Evolus (NASDAQ:EOLS) Rating Increased to Buy at Wall Street Zen - marketbeat.com

Needham Maintains Evolus(EOLS.US) With Hold Rating - moomoo.com

BTIG Maintains Evolus(EOLS.US) With Buy Rating, Maintains Target Price $13 - Moomoo

Evolus Inc (EOLS) Stock News Today - TradingKey

Evolus, Inc. (EOLS) Investor Outlook: Analyzing 97.93% Potential Upside in the Aesthetic Market - DirectorsTalk Interviews

Stifel Maintains Evolus(EOLS.US) With Buy Rating, Maintains Target Price $17 - Moomoo

Evolus, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:EOLS) 2026-08-06 - Seeking Alpha

Evolus Inc (EOLS) (Q2 2026) Earnings Call Highlights: Revenue Su - GuruFocus

Earnings call transcript: Evolus tops revenue forecast in Q2 2026, shares rise - Investing.com UK

Evolus, Inc. Q2 2026 Financial Results: Revenue, Risks, and Key Business Updates - Minichart

Evolus Inc (EOLS) (Q2 2026) Earnings Call Highlights: Revenue Surges 21% and Adjusted EBITDA ... - Yahoo Finance

Evolus Q2 Earnings Call Highlights - MarketBeat

Is Evolus Inc (EOLS) Undervalued After Q2 Earnings Beat? EPS: -0 - GuruFocus

Evolus Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Evolus Q2 2026 slides: profitability streak continues, guidance raised - Investing.com

Evolus, Inc. Q2 2026: Revenue $84.08M, EPS ($0.12) — 10-Q Summary - TradingView

Evolus (EOLS) Releases Q2 2026 Earnings: Revenue Growth and Narrower Losses - Quiver Quantitative

Evolus (Nasdaq: EOLS) posts higher sales and manages sizable debt load - stocktitan.net

Evolus Q2 revenue rises 21%, lifts 2026 outlook - TradingView

Evolus Q2 2026 Earnings: Revenue Rises 21% as Adjusted EBITDA Stays Positive - TradingKey

Evolus (NASDAQ: EOLS) lifts 2026 guidance after Q2 revenue hits $84.1 million - Stock Titan

Evolus Reports Strong Second Quarter 2026 Financial Results; Delivers Third Consecutive Quarter of Positive Adjusted EBITDA and Raises Full-Year 2026 Financial Outlook - marketscreener.com

Finanzdaten der Evolus Inc-Aktie (EOLS)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie EOLS